therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
<Aprepitant, mechanism, rifampin>, <Aprepitant, mechanism, phenytoin>, <Aprepitant, mechanism, aprepitant>